Holen Sie sich die Stockscreener-App
50.97
0.63%
-0.16
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Hims & Hers: A High-Risk Bet (NYSE:HIMS) - Seeking Alpha
Hims & Hers Redefines Virtual Care With Integrated Tech Platforms - Zacks Investment Research
HIMS Shares Decline Amid Lower Revenue Per Order For GLP-1 Following Novo Nordisk Collaboration Termination, Securities Class Action Pending — Hagens Berman - TradingView
HIMS LAWSUIT ALERT: The Gross Law Firm Notifies Hims & Hers Health, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - PR Newswire
HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS - GlobeNewswire
2025-08-06 | Levi & Korsinsky Urges Hims & Hers Health, Inc. (HIMS) Shareholders to Act Before Lead Plaintiff Deadline August 25, 2025 | NYSE:HIMS | Press Release - Stockhouse
HIMS Shares Decline Amid Lower Revenue Per Order For GLP-1 Following Novo Nordisk Collaboration Termination, Securities Class Action Pending -- Hagens Berman - GlobeNewswire Inc.
Hims & Hers: From Telehealth To Wellness Hub, The Bright Future (NYSE:HIMS) - Seeking Alpha
Hims & Hers: Still Growing After Breakup With Novo Nordisk (NYSE:HIMS) - Seeking Alpha
Hims & Hers: GLP-1 Strategy Is On Dubious Grounds (NYSE:HIMS) - Seeking Alpha
Hims & Hers (HIMS) Falls 12.36% on Weaker Revenues - Insider Monkey
Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesHIMS - PR Newswire
Diagnosis: Hims & Hers' August Price Dip Is an Opportunity to Buy - MarketBeat
Contact Levi & Korsinsky by August 25, 2025 to Join Class Action Against Hims & Hers Health, Inc. (HIMS) - The Globe and Mail
Hims & Hers Health, Inc. (NYSE:HIMS) Q2 2025 Earnings Call Transcript - Insider Monkey
Hims & Hers Health (NYSE:HIMS) Shares Gap Down on Disappointing Earnings - Defense World
Hims & Hers Reports Strong Growth Amid Challenges - TipRanks
HIMS LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces - GlobeNewswire
Hims & Hers Health, Inc.: Please contact the Portnoy Law - GlobeNewswire
HIMS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages - GlobeNewswire
Palantir, Pfizer, Vertex, Hims & Hers, Coinbase, BP, and More Stock Market Movers - Barron's
Shareholders of Hims & Hers Health, Inc. Should Contact - GlobeNewswire
US Market Under Pressure: Amazon, Eastman Chemical, and Hims & Hers Among Top Losers - FinancialContent
Why Hims & Hers Health (HIMS) Faces New Questions After Revenue Guidance Miss and Regulatory Setbacks - simplywall.st
Hims & Hers Stock Slides on Earnings. Weight-Loss Drugs Are Just One Problem. - Barron's
Wait Out The GLP-1 Storm – Buy The Hims And Hers Post-Earnings Dip (NYSE:HIMS) - Seeking Alpha
Hims & Hers Stock Is Trading Lower Tuesday: What's Going On? - Benzinga
Deadline Alert: Hims & Hers Health, Inc. (HIMS) Investors - GlobeNewswire
Hims & Hers Stock Sags As Revenue Falls Short Of Hype - Finimize
HIMS Stock Plunges Following Q2 Earnings Miss, Gross Margin Down - Yahoo Finance
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - GlobeNewswire
Hims & Hers Health Posts Weak Q2; Heading Into More Near-Term Challenges, Analysts Say - Benzinga
Why Hims & Hers Health Stock Just Dropped - Nasdaq
Hims & Hers Health, DuPont, Gartner: Trending Tickers - Yahoo Finance
Hims & Hers stock slides 5% after second quarter revenue misses forecasts - Yahoo Finance
Hims & Hers Hits $1.5B Revenue, Eyes $2.4B in 2025 with AI Telehealth - WebProNews
Hims & Hers Q2 EarningsWall Street Sells Despite GLP Compounding Promises (NYSE:HIMS) - Seeking Alpha
Hims Shares Drop After Quarterly Sales Miss Wall Street’s Estimates - Bloomberg.com
Hims & Hers: Mixed Q2 Results Signal Valuation Concerns - Trefis
Hims & Hers Stock Nosedives After Q2 Revenue Miss Despite 73% Growth - Yahoo Finance
Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Seeking Recovery for InvestorsContact Levi & Korsinsky - PR Newswire
Earnings live: Palantir stock pops on raised outlook, Hims & Hers tumbles - Yahoo Finance
HIMS CLASS ACTION: Hims & Hers Health, Inc. Investors that - GlobeNewswire
Hims & Hers: Buy The Core Engine, Not The Headline (NYSE:HIMS) - Seeking Alpha
Hold Rating for Hims & Hers Health Amid Mixed Results and Growth Investments - TipRanks
Hims & Hers: Buy The Earnings Dip, Slowly (Rating Downgrade) (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Stock Plunges Over 13% In Tuesday Pre-Market: What's Going On? - Benzinga
Trending tickers: Diageo, Palantir, Saudi Aramco, American Eagle and Hims & Hers - uk.finance.yahoo.com
Avantax Advisory Services Inc. Sells 5,127 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) - Defense World
Hims & Hers Health Inc (HIMS) Q2 2025 Earnings Call Highlights: Robust Revenue Growth Amid ... - Yahoo Finance
Hims & Hers Health Reports Strong Q2 2025 Growth - TipRanks
Palantir, Hims & Hers, American Eagle, Joby Aviation And AMD: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Hims & Hers: Scaling the Future of Digital Health and Capturing a $2 Trillion Wellness Market - AInvest
Lost Money on Hims & Hers Health, Inc. (HIMS)? Join Class Action Before August 25, 2025Contact Levi & Korsinsky - Stockhouse
Cautious Outlook for Hims & Hers Health Amid Revenue Shortfall and Adjusted Guidance - TipRanks
Earnings call transcript: Hims Hers Health Q2 2025 beats EPS forecasts - Investing.com
Hims & Hers Health Stock Stumbles After Earnings. Here’s Why. - Barron's
Hims & Hers Health, Inc. (HIMS) Misses Q2 Earnings and Revenue Estimates - Yahoo Finance
0.30%
13.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):